loadpatents
Patent applications and USPTO patent grants for von Janta-Lipinski; Martin.The latest application filed is for "beta-l-n4 hydroxycytosine deoxynucleosides and their use as pharmaceutical agents in the prophylaxis or therapy of viral diseases".
Patent | Date |
---|---|
Beta-L-N4 Hydroxycytosine Deoxynucleosides and their use as Pharmaceutical Agents in the Prophylaxis or Therapy of Viral Diseases App 20140031309 - Matthes; Eckart ;   et al. | 2014-01-30 |
Beta-L-N4-Hydroxycytosine Deoxynucleosides and their use as Pharmaceutical Agents in the Prophylaxis or Therapy of Viral Diseases App 20090105186 - Matthes; Eckart ;   et al. | 2009-04-23 |
Chimeric oligonucleotides and the use thereof App 20010039263 - Matthes, Eckart ;   et al. | 2001-11-08 |
2',3'-dideoxynucleoside pyrimidine compounds and carbocyclic analogs Grant 5,496,935 - Matthes , et al. March 5, 1 | 1996-03-05 |
Fluorinated nucleosides and method for treating retrovirus infections therewith Grant 4,963,662 - Matthes , et al. October 16, 1 | 1990-10-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.